Generic Posfrea Availability
Last updated on May 7, 2025.
Posfrea is a brand name of palonosetron, approved by the FDA in the following formulation(s):
POSFREA (palonosetron hydrochloride - solution;intravenous)
-
Manufacturer: AVYXA HOLDINGS
Approval date: March 1, 2016
Strength(s): EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML) (discontinued) [RLD], EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) [RLD]
Is there a generic version of Posfrea available?
No. There is currently no therapeutically equivalent version of Posfrea available in the United States.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Posfrea. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: Generic Drug FAQ.
More about Posfrea (palonosetron)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- Drug class: 5HT3 receptor antagonists
- Breastfeeding
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Related/similar drugs
Zofran
Zofran (ondansetron) is used to prevent nausea and vomiting caused by surgery or cancer medicines ...
Ativan
Ativan is a benzodiazepine used to treat anxiety disorders or anxiety associated with depression ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Reglan
Reglan (metoclopramide) is used to treat heartburn caused by gastric reflux. Includes Reglan side ...
Decadron
Decadron is used for addison's disease, adrenal insufficiency, adrenocortical insufficiency ...
Zofran ODT
Zofran ODT is used for nausea/vomiting, nausea/vomiting, chemotherapy induced, nausea/vomiting ...
Emend
Emend is used to prevent nausea and vomiting caused by chemotherapy. Learn about side effects ...
Granisetron
Granisetron is used for nausea/vomiting, nausea/vomiting, chemotherapy induced, nausea/vomiting ...
Aprepitant
Aprepitant is used for nausea/vomiting, nausea/vomiting, chemotherapy induced, nausea/vomiting ...
Amisulpride
Amisulpride is used for nausea/vomiting, postoperative, persistent depressive disorder, schizophrenia
Glossary
| Term | Definition |
|---|---|
| Drug Patent | A drug patent is assigned by the U.S. Patent and Trademark Office and assigns exclusive legal right to the patent holder to protect the proprietary chemical formulation. The patent assigns exclusive legal right to the inventor or patent holder, and may include entities such as the drug brand name, trademark, product dosage form, ingredient formulation, or manufacturing process A patent usually expires 20 years from the date of filing, but can be variable based on many factors, including development of new formulations of the original chemical, and patent infringement litigation. |
| Drug Exclusivity | Exclusivity is the sole marketing rights granted by the FDA to a manufacturer upon the approval of a drug and may run simultaneously with a patent. Exclusivity periods can run from 180 days to seven years depending upon the circumstance of the exclusivity grant. |
| RLD | A Reference Listed Drug (RLD) is an approved drug product to which new generic versions are compared to show that they are bioequivalent. A drug company seeking approval to market a generic equivalent must refer to the Reference Listed Drug in its Abbreviated New Drug Application (ANDA). By designating a single reference listed drug as the standard to which all generic versions must be shown to be bioequivalent, FDA hopes to avoid possible significant variations among generic drugs and their brand name counterpart. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.